Wyeth Limited
About Wyeth Limited
Data last updated:
Wyeth Limited was a public limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 September 1947.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN L85190MH1947PLC005963. It is recorded as listed by MCA, but its shares were delisted from BSE on 25 Mar 2015 · merger, and no longer trade on a stock exchange.
The company had an authorised share capital of ₹23 Cr and a paid-up capital of ₹22.72 Cr. It was led by directors including Aijaz Rehmatali Tobaccowalla (Managing Director) and Sekhar Natarajan.
Its last annual general meeting (AGM) was held on 10 November 2014, and its latest financial statements are for the year ended 31 March 2014. The registered office was at Level 6 Platina Plot No. C – 59 G Block Bandra – Kurla Complex Bandra (E), Mumbai, Maharashtra, India – 400098.
The company was associated with 1 brand: Wyeth Lederle. Court records list 139 cases involving the company, including 100 filed by the company and 39 filed against it; 17 cases are pending. The company has 12 deals on record (11 market trades, 1 acquisition); the latest was in November 2013.
Company details
CIN history
Wyeth has one previous CIN (Corporate Identification Number): U85190MH1947PLC005963. The current CIN is L85190MH1947PLC005963, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85190MH1947PLC005963 | Current |
| U85190MH1947PLC005963 | Previous |
Contact details
Wyeth Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressLevel 6 Platina Plot No. C – 59 G Block Bandra – Kurla Complex Bandra (E), Mumbai, Maharashtra, India – 400098
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Wyeth operates one associated brand: Wyeth Lederle. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products are distributed via standalone pharmacy operations. | wyethindia.com |
Financials of Wyeth Limited
FY 2014 filings availableFinancial Statement Summary
| Metrics | FY 2013-14 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2013-14 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Wyeth Limited, buy the company report.
Board of directors and KMP of Wyeth Limited
Wyeth Limited currently reports 6 directors and 2 key managerial personnel. 13 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neema Thakore Also directs: Naishadh Investment and Finance P.Ltd. | Company Secretary | 12 Mar 2001 | 25 Years 8 Months | As last reported |
| Sekhar Natarajan Also directs: Agvaya LLP, Ingersoll-Rand (India) Limited, Colgate-Palmolive (India) Limited and 2 more | Director | 05 Aug 2011 | 15 Years 3 Months | As last reported |
| Vivek Dhariwal Also directs: Windlas Biotech Limited | Director | 03 May 2011 | 15 Years 6 Months | As last reported |
| Sridhar Subramaniam Also directs: Gestion Advisory Services LLP | Director | 21 May 2012 | 14 Years 5 Months | As last reported |
| Aijaz Rehmatali Tobaccowalla | Managing Director | 28 Jun 2012 | 14 Years 4 Months | As last reported |
| Sunil Siddharth Lalbhai Also directs: Britannia Industries Ltd, The Bombay Dyeing and Manufacturing Company Limited, Amal Limited and 5 more | Director | 27 Mar 2002 | 24 Years 7 Months | As last reported |
Deals & funding
Wyeth Limited has 12 deals on record (11 market trades, 1 acquisition); the latest was in November 2013.
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2013 | Acquisition | Undisclosed | Buyer: Pfizer Limited |
| Jan 2010 | Market trade | ₹15.13 Cr | Seller: Reliance Mutual Fund A/C Reliance Long Term Equity Fund |
| Mar 2007 | Market trade | ₹18.57 Cr | Buyer: Reliance Capital Trustee Seller: Citigroup Global Market M |
| Jan 2007 | Market trade | ₹7.58 Cr | Buyer: Reliance Capital Trustee Seller: Citigroup Global Markets |
| Feb 2006 | Market trade | ₹7.8 Cr | Seller: Fidelity Investment Mgmt |
To see the full deal history of Wyeth Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Wyeth Limited has 139 court cases on record: 100 filed by Wyeth, 39 filed against it. 17 cases are pending and 122 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 81 | 23 | 11 |
| District courts | 51 | 14 | 6 |
| Supreme Court | 7 | 2 | 0 |
Cases on record (5 of 139)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Sun Pharmaceutical Industries Ltd | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CHAMBER SUMMONS) | Filed by the company against Nectar Laboratories Ltd | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Sun Pharmaceutical Industries Ltd | Disposed |
| High Court of Karnataka | Interim or miscellaneous application | Filed against the company by M/S Vijayanand Roadlines Ltd | Disposed |
| High Court of Karnataka | Appeal | Filed against the company by M/S Vijayanand Roadlines Ltd | Disposed |
To see the full case history of Wyeth Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wyeth Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Wyeth Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Wyeth Limited has 32 board changes on record since 1985: 20 appointments and 12 cessations. The latest: Pradip Panalal Shah ceased to be Director on 30 Sep 2014.
23 earlier events are in the company report.
Frequently asked questions
Wyeth has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Wyeth was a public limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 20 September 1947 and is registered under CIN L85190MH1947PLC005963. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Wyeth was incorporated on 20 September 1947. It is registered with the Registrar of Companies, Mumbai.
Wyeth had 8 directors and KMP:
- Aijaz Rehmatali Tobaccowalla - Managing Director
- Sekhar Natarajan - Director
- Vivek Dhariwal - Director
- Sridhar Subramaniam - Director
- Sunil Siddharth Lalbhai - Director
- Kamalesh Kumar Maheshwari - Director
- Neema Thakore - Company Secretary
- Darshak Pradip Bhagat - Cfo
The CIN (Corporate Identification Number) of Wyeth is L85190MH1947PLC005963. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wyeth is recorded as a listed company by MCA, but its shares were delisted from BSE on 25 Mar 2015 · merger, and no longer trade on a stock exchange.
The registered office of Wyeth is at Level 6 Platina Plot No. C – 59 G Block Bandra – Kurla Complex Bandra E, Mumbai, Maharashtra, India – 400098.
The latest financial statements of Wyeth on record with the MCA are for the year ended 31 March 2014. Its last annual general meeting was held on 10 November 2014. Year-wise statements from 2015 are in the company report.
Wyeth operated in the pharma industry, in the drug formulation and development segment.
Wyeth has 12 deals on record (11 market trades, 1 acquisition); the latest was in November 2013.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
